New biomarker which detects LG3BP and C163A levels in the blood samples can effectively be used distinguish benign lung cancer nodules from malignant ones. The findings of this study are published in the journal of IChest/I.
Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients. Many are "incidentally detected," meaning they are found during evaluation for an unrelated cause (for example, a chest X-ray after a fall). Although 75 to ...
New biomarker which detects LG3BP and C163A levels in the blood samples can effectively be used distinguish benign lung cancer nodules from malignant ones. The findings of this study are published in the journal of IChest/I.
Every year, health care providers in the United States discover more than 1.6 million lung nodules in patients. Many are "incidentally detected," meaning they are found during evaluation for an unrelated cause (for example, a chest X-ray after a fall). Although 75 to ...